Prevalence of fetal ultrasonographic soft markers in antenatal women and their pregnancy outcomes: a cross-sectional study

Shaily Agarwal; Monica Sahu; Renu Gupta; Pavika Lal

doi:10.18203/2320-1770.ijrcog20242800

Authors

Shaily Agarwal Department of Obstetrics and Gynaecology, GSVM Medical College Kanpur, Uttar Pradesh, India
Monica Sahu Department of Obstetrics and Gynaecology, GSVM Medical College Kanpur, Uttar Pradesh, India
Renu Gupta Department of Obstetrics and Gynaecology, GSVM Medical College Kanpur, Uttar Pradesh, India
Pavika Lal Department of Obstetrics and Gynaecology, GSVM Medical College Kanpur, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20242800

Keywords:

Prevalence, Pregnant women, Nuchal translucency, Hyperechogenic bowel, Pyelectasis

Abstract

Objectives: Estimating soft marker prevalence during first and second trimester ultrasound scans and determining the relationship between nuchal translucency (NT) measurements and sociodemographic variables in the antenatal population receiving care at our facility.

Methods: This hospital-based observational study, conducted from January 2020 to November 2021, included 300 pregnant women receiving antenatal care at our institute. Soft markers studied included NT and absence of nasal bone for the first trimester and echogenic intracardiac focus (EICF), hyperechogenic bowel, choroid plexus cyst (CPC), mild renal pyelectasis, and limb shortening for the second trimester. For ultrasonographic examination, a HITACHI –ALOKA -6 USG equipment was used via transabdominal route. Wherever applicable, independent sample t test, chi-square test, and fisher's exact test were used to examine demographic factors and NT. To analyse the data, S.P.S.S version 23 was utilized.

Results: The mean age of the participants was 24.96 years, and 41% (n=123) were primigravida and 59% (n=177) were multigravida. Most pregnant women (79%, n=237) were low-risk. Prevalence of Increased NT was 2.66% (n=9), hypoplasia or absence of NB was none, EICF was 2.33% (n=7), Hyperechogenic bowel was 0.33% (n=1), CPC was none, mild renal pyelectasis was 0.66% (n=2), and limb shortening was 0.33%. Relationship between obstetric risk factors and increased NT (2=12.22, p=0.006) and mean age of participants with increased NT (t=-2.625, p=0.009) was statistically significant.

Conclusions: First-trimester fetal NT screening should be done for pregnant women over 30 and multigravida. Soft markers in pregnant women need a thorough diagnostic evaluation to rule out fetal abnormalities.

Metrics

Metrics Loading ...

References

Ailes EC, Gilboa SM, Riehle‐Colarusso T, Johnson CY, Hobbs CA, Correa A, et al. Prenatal diagnosis of nonsyndromic congenital heart defects. Prenat Diagn 2014;34:214-22.

Van den Hof M, Wilson R, Diagnostic Imaging Committee SoOaGoC, Genetics Committee SoOaGoC. Fetal soft markers in obstetric ultrasound. J Obstet Gynaecol Can. 2005;27:592–636.

Smith-Bindman R, Chu P, Goldberg JD. Second trimester prenatal ultrasound for the detection of pregnancies at increased risk of Down syndrome. Prenat Diagn. 2007;27:535-44.

Nicolaides KH (2004) Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol. 2007;191:45–67.

Sethna F, Tennant PW, Rankin J, C Robson S (2011) Prevalence, natural history, and clinical outcome of mild to moderate ventriculomegaly. Obstet Gynecol. 2011;117: 867-76.

Liu Y, Jing X, Xing L, Liu S, Liu J, Cheng J, et al. Non-invasive prenatal screening based on second-trimester ultrasonographic soft markers in low-risk pregnant women. Front Genet. 202123;12:793894.

Minnella GP, Crupano FM, Syngelaki A, Zidere V, Akolekar R, Nicolaides KH. Diagnosis of major heart defects by routine first-trimester ultrasound examination: association with increased nuchal translucency, tricuspid regurgitation and abnormal flow in ductus venosus. Ultrasound Obstet Gynecol. 2020;55:637-44.

Kagan KO, Cicero S, Staboulidou I, Wright D, Nicolaides KH. Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation. Ultrasound Obstet Gynecol. 2009;33:259-64.

Bromley B, Lieberman E, Laboda L, Benacerraf BR. Echogenic intracardiac focus: a sonographic sign for fetal down syndrome. Obstet Gynecol. 1995;86:998-1001.

Sepulveda W, Sebire NJ. Fetal echogenic bowel: a complex scenario. Ultrasound Obstet Gynecol. 2000;16:510-4.

Chitty LS, Chudleigh P, Wright E, Campbell S, Pembrey M. The significance of choroid plexus cysts in an unselected population: results of a multicenter study. Ultrasound Obstet Gynecol. 1998;12:391-7.

Dagklis T, Plasencia W, Maiz N, Duarte L, Nicolaides KH. Choroid plexus cyst, intracardiac echogenic focus, hyperechogenic bowel and hydronephrosis in screening for trisomy 21 at 11+0 to 13+6 weeks. Ultrasound Obstet Gynecol. 2008;31:132-5.

Nyberg DA, Resta RG, Luthy DA, Hickok DE, Williams MA. Humerus and femur length shortening in the detection of Down's syndrome. Am J Obstet Gynecol. 1993;168:534-9.

Sulaiman B, Shehu CE, Panti AA, Saidu SA, Onankpa B, Ekele BA. Prevalence and outcome of increased nuchal translucency in usmanu danfodiyo university teaching hospital, Sokoto, Nigeria: A cohort study. Niger J Clin Pract. 2020;23(6):864-9.

Masihi S, Barati M, Mohamadjafari R, Hashemi M. Assessemnt of nasal bone in first trimester screening for chromosomal abnormalities in Khuzestan. Iran J Reprod Med. 2014;12(5):321-6.

Fallahian R, Kalantary M, Keshavarz E, Mohammadi K. Assessing the prevalence of eif in second trimester ultrasound screening in the foetuses of mothers resorting to Mahdiyeh medical center of tehran from 2014 to 2016 and their follow up. Biomed Pharmacol J. 2017;10:2.

Simon-Bouy B, Satre V, Ferec C, Malinge MC, Girodon E, Denamur E, Leporrier N, Lewin P, Forestier F, Muller F; French Collaborative Group. Hyperechogenic fetal bowel: a large French collaborative study of 682 cases. Am J Med Genet A. 2003;121(3):209-13.

Signorelli M, Cerri V, Taddei F, Groli C, Bianchi UA. Prenatal diagnosis and management of mild fetal pyelectasis: implications for neonatal outcome and follow-up. Eur J Obstet Gynecol Reprod Biol. 2005;118(2):154-9.

Pandya, PP, Hilbert F, Snijders RJ, Nicolaides KH. Nuchal translucency thickness and crown-rump length in twin pregnancies with chromosomally abnormal fetuses. J Ultra Med. 1995;14:565-8.

Snijders RJM, Thom EA, Zachary JM, Platt LD, Greene N, Jackson LG, et al. First-trimester trisomy screening: nuchal translucency measurement training and quality assurance to correct and unify technique. Ultra Obst Gynecol. 2002;19(4):353-9.

Winter TC, Anderson AM, Cheng EY, Komarniski CA, Souter VL, Uhrich SB, Nyberg DA. Echogenic intracardiac focus in 2nd-trimester fetuses with trisomy 21: usefulness as a US marker. Radiology. 2000;216(2):450-6.

Anderson N, Jyoti R. Relationship of isolated fetal intracardiac echogenic focus to trisomy 21 at the mid-trimester sonogram in women younger than 35 years. Ultrasound Obstet Gynecol. 2003;21(4):354-8.